XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Shareholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of change in accounting principle for ASU 2022-02
Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Cumulative effect of change in accounting principle for ASU 2022-02
Accumulated Other Comprehensive Income (Loss), Net of Tax
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2021     72,017,126          
Balance at beginning of period (in shares) at Dec. 31, 2021               2,407,898
Balance at beginning of period at Dec. 31, 2021 $ 2,966,451   $ 72,017 $ 1,924,813 $ 1,006,436   $ 15,590 $ (52,405)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     145,393          
Issuance of restricted shares 1,341   $ 145 1,196        
Proceeds from exercise of stock options (in shares)     49,803          
Proceeds from exercise of stock options 1,445   $ 50 1,395        
Share-based compensation 1,298     1,298        
Purchase of treasury shares (in shares)               365,340
Purchase of treasury shares (17,234)             $ (17,234)
Net income 81,698       81,698      
Dividends on common shares (10,409)       (10,409)      
Other comprehensive loss during the period (17,431)           (17,431)  
Balance at end of period (in shares) at Mar. 31, 2022     72,212,322          
Balance at end of period (in shares) at Mar. 31, 2022               2,773,238
Balance at end of period at Mar. 31, 2022 3,007,159   $ 72,212 1,928,702 1,077,725   (1,841) $ (69,639)
Balance at beginning of period (in shares) at Dec. 31, 2021     72,017,126          
Balance at beginning of period (in shares) at Dec. 31, 2021               2,407,898
Balance at beginning of period at Dec. 31, 2021 $ 2,966,451   $ 72,017 1,924,813 1,006,436   15,590 $ (52,405)
Balance at end of period (in shares) at Dec. 31, 2022     72,263,727          
Balance at end of period (in shares) at Dec. 31, 2022 2,894,677             2,894,677
Balance at end of period at Dec. 31, 2022 $ 3,197,400 $ 1,277 $ 72,264 1,935,211 1,311,258 $ 1,277 (46,507) $ (74,826)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-02 [Member]              
Issuance of restricted shares (in shares)     101,510          
Issuance of restricted shares $ 0   $ 101 (101)        
Issuance of common shares pursuant to PSU agreements (in shares)     102,973          
Issuance of common shares pursuant to PSU agreements 0   $ 103 (103)        
Proceeds from exercise of stock options (in shares)     16,000          
Proceeds from exercise of stock options 476   $ 16 460        
Share-based compensation 2,197     2,197        
Purchase of treasury shares (in shares)               215,670
Purchase of treasury shares (9,058)             $ (9,058)
Net income 60,421       60,421      
Dividends on common shares (10,444)       (10,444)      
Other comprehensive loss during the period $ 10,926           10,926  
Balance at end of period (in shares) at Mar. 31, 2023     72,484,210          
Balance at end of period (in shares) at Mar. 31, 2023 3,110,347             3,110,347
Balance at end of period at Mar. 31, 2023 $ 3,253,195   $ 72,484 $ 1,937,664 $ 1,362,512   $ (35,581) $ (83,884)